Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reiss

Showing results (141-150 of 269) with videos related to

Pageof 27
Sort By:
Cell Reports|November 13, 2024
Cancer-associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironmentXu Han, Michelle Burrows, Laura C Kim, et al.
American Journal of Clinical Oncology|March 20, 2018
Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low ToxicityBrian C Baumann, Jenny Wei, John P Plastaras, et al.
American Journal of Hematology|January 23, 2010
Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family studyChristine E McLaren, James C Barton, John H Eckfeldt, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 13, 2007
Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) studyLari B Wenzel, Roger Anderson, Diane C Tucker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2014
A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosisKim A Reiss, Joseph M Herman, Marianna Zahurak, et al.
Journal of Genetic Counseling|February 10, 2018
Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome SequencingFrances L Lynch, Patricia Himes, Marian J Gilmore, et al.
Genetic Testing|October 24, 2007
HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screeningJames C Barton, Ronald T Acton, Catherine Leiendecker-Foster, et al.
American Journal of Hematology|August 30, 2007
Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screeningJames C Barton, Ronald T Acton, Catherine Leiendecker-Foster, et al.
Clinical Epigenetics|December 3, 2022
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrenceThatcher R Heumann, Marina Baretti, Elizabeth A Sugar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2021
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>Kim A Reiss, Rosemarie Mick, Mark H O'Hara, et al.
Pageof 27

Showing results (141-150 of 269) with videos related to

Sort By:
Pageof 27
Cell Reports|November 13, 2024
Cancer-associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironmentXu Han, Michelle Burrows, Laura C Kim, et al.
American Journal of Clinical Oncology|March 20, 2018
Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low ToxicityBrian C Baumann, Jenny Wei, John P Plastaras, et al.
American Journal of Hematology|January 23, 2010
Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family studyChristine E McLaren, James C Barton, John H Eckfeldt, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 13, 2007
Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) studyLari B Wenzel, Roger Anderson, Diane C Tucker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2014
A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosisKim A Reiss, Joseph M Herman, Marianna Zahurak, et al.
Journal of Genetic Counseling|February 10, 2018
Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome SequencingFrances L Lynch, Patricia Himes, Marian J Gilmore, et al.
Genetic Testing|October 24, 2007
HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screeningJames C Barton, Ronald T Acton, Catherine Leiendecker-Foster, et al.
American Journal of Hematology|August 30, 2007
Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screeningJames C Barton, Ronald T Acton, Catherine Leiendecker-Foster, et al.
Clinical Epigenetics|December 3, 2022
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrenceThatcher R Heumann, Marina Baretti, Elizabeth A Sugar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2021
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>Kim A Reiss, Rosemarie Mick, Mark H O'Hara, et al.
Pageof 27